通过皮肤进行电神经刺激治疗难治的儿童便秘:临床观察和比较研究
Ilke Aktas1,2, Nevzat Aykut Bayrak3,4, Rabia Gönül Sezer Yamanel2
1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Istanbul Medeniyet University.
European journal of gastroenterology & hepatology
|September 3, 2025
概括
通过皮肤进行的电神经刺激 (TENS) 改善了儿童的便秘症状,但效果是暂时的. 每周两次和每周三次的TENS在儿童难治便秘的疗效相似.
科学领域:
- 儿童胃肠病学
- 神经调节疗法
- 功能性胃肠疾病
背景情况:
- 这是一个常见的儿科问题.
- 目前的治疗方法可能有局限性或副作用.
- 探索新的治疗方法是必不可少的.
研究的目的:
- 评估通过皮肤电神经刺激 (TENS) 在治疗儿科难治便秘的有效性.
- 为了比较TENS的有效性,每周使用两次和每周使用三次.
主要方法:
- 一项随机对照试验,涉及6至17岁的儿童,患有难以治愈的便秘.
- 儿童接受了为期4周的TENS治疗 (每次20分钟).
- 两组:第一组 (每周3次) 和第二组 (每周2次);治疗前,治疗期间和治疗后的结果.
主要成果:
- 这两种TENS方案显著增加了排便频率,减少了疼痛和便失禁.
- 治疗结束后4周没有持续改善.
- 每周两次使用TENS的疗效与每周三次使用TENS的疗效相当.
结论:
- 对于患有难以治愈的便秘的儿童来说,TENS具有潜在的短期益处.
- 治疗频率 (每周两次或三次) 并没有显著改变结果.
- 需要使用更大的样本进行进一步的研究,以确认非劣质性和长期疗效.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
238
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
238
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
294
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
294